153 related articles for article (PubMed ID: 11083552)
1. Role of platelet-derived growth factor as an adjunct to surgery in the management of pressure ulcers.
Kallianinen LK; Hirshberg J; Marchant B; Rees RS
Plast Reconstr Surg; 2000 Nov; 106(6):1243-8. PubMed ID: 11083552
[TBL] [Abstract][Full Text] [Related]
2. Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. Diabetic Ulcer Study Group.
Steed DL
J Vasc Surg; 1995 Jan; 21(1):71-8; discussion 79-81. PubMed ID: 7823364
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human platelet-derived growth factor-BB for the treatment of chronic pressure ulcers.
Robson MC; Phillips LG; Thomason A; Altrock BW; Pence PC; Heggers JP; Johnston AF; McHugh TP; Anthony MS; Robson LE
Ann Plast Surg; 1992 Sep; 29(3):193-201. PubMed ID: 1524367
[TBL] [Abstract][Full Text] [Related]
4. A phase II study to evaluate recombinant platelet-derived growth factor-BB in the treatment of stage 3 and 4 pressure ulcers.
Mustoe TA; Cutler NR; Allman RM; Goode PS; Deuel TF; Prause JA; Bear M; Serdar CM; Pierce GF
Arch Surg; 1994 Feb; 129(2):213-9. PubMed ID: 8304833
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study.
Wieman TJ; Smiell JM; Su Y
Diabetes Care; 1998 May; 21(5):822-7. PubMed ID: 9589248
[TBL] [Abstract][Full Text] [Related]
6. Tissue repair processes in healing chronic pressure ulcers treated with recombinant platelet-derived growth factor BB.
Pierce GF; Tarpley JE; Allman RM; Goode PS; Serdar CM; Morris B; Mustoe TA; Vande Berg J
Am J Pathol; 1994 Dec; 145(6):1399-410. PubMed ID: 7992843
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human platelet-derived growth factor for refractory nondiabetic ulcers: a retrospective series.
Harrison-Balestra C; Eaglstein WH; Falabela AF; Kirsner RS
Dermatol Surg; 2002 Aug; 28(8):755-9; discussion 759-60. PubMed ID: 12174074
[TBL] [Abstract][Full Text] [Related]
8. A phase I/II clinical trial to evaluate a combination of recombinant human platelet-derived growth factor-BB and recombinant human insulin-like growth factor-I in patients with periodontal disease.
Howell TH; Fiorellini JP; Paquette DW; Offenbacher S; Giannobile WV; Lynch SE
J Periodontol; 1997 Dec; 68(12):1186-93. PubMed ID: 9444594
[TBL] [Abstract][Full Text] [Related]
9. Periodontal regeneration in humans using recombinant human platelet-derived growth factor-BB (rhPDGF-BB) and allogenic bone.
Nevins M; Camelo M; Nevins ML; Schenk RK; Lynch SE
J Periodontol; 2003 Sep; 74(9):1282-92. PubMed ID: 14584860
[TBL] [Abstract][Full Text] [Related]
10. The use of becaplermin (rhPDGF-BB) gel for chronic nonhealing ulcers. A retrospective analysis.
Mandracchia VJ; Sanders SM; Frerichs JA
Clin Podiatr Med Surg; 2001 Jan; 18(1):189-209, viii. PubMed ID: 11344978
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers: a combined analysis of four randomized studies.
Smiell JM; Wieman TJ; Steed DL; Perry BH; Sampson AR; Schwab BH
Wound Repair Regen; 1999; 7(5):335-46. PubMed ID: 10564562
[TBL] [Abstract][Full Text] [Related]
12. Becaplermin gel in the treatment of pressure ulcers: a phase II randomized, double-blind, placebo-controlled study.
Rees RS; Robson MC; Smiell JM; Perry BH
Wound Repair Regen; 1999; 7(3):141-7. PubMed ID: 10417749
[TBL] [Abstract][Full Text] [Related]
13. Effect of extensive debridement and treatment on the healing of diabetic foot ulcers. Diabetic Ulcer Study Group.
Steed DL; Donohoe D; Webster MW; Lindsley L
J Am Coll Surg; 1996 Jul; 183(1):61-4. PubMed ID: 8673309
[TBL] [Abstract][Full Text] [Related]
14. Platelet-derived growth factor BB for the treatment of chronic pressure ulcers.
Robson MC; Phillips LG; Thomason A; Robson LE; Pierce GF
Lancet; 1992 Jan; 339(8784):23-5. PubMed ID: 1345953
[TBL] [Abstract][Full Text] [Related]
15. Recombinant human platelet-derived growth factor BB (rhPDGF-BB) and beta-tricalcium phosphate/collagen matrix enhance fracture healing in a diabetic rat model.
Al-Zube L; Breitbart EA; O'Connor JP; Parsons JR; Bradica G; Hart CE; Lin SS
J Orthop Res; 2009 Aug; 27(8):1074-81. PubMed ID: 19170096
[TBL] [Abstract][Full Text] [Related]
16. Platelet-derived growth factor stimulates bone fill and rate of attachment level gain: results of a large multicenter randomized controlled trial.
Nevins M; Giannobile WV; McGuire MK; Kao RT; Mellonig JT; Hinrichs JE; McAllister BS; Murphy KS; McClain PK; Nevins ML; Paquette DW; Han TJ; Reddy MS; Lavin PT; Genco RJ; Lynch SE
J Periodontol; 2005 Dec; 76(12):2205-15. PubMed ID: 16332231
[TBL] [Abstract][Full Text] [Related]
17. Effect of rhPDGF-BB delivery on mediators of periodontal wound repair.
Cooke JW; Sarment DP; Whitesman LA; Miller SE; Jin Q; Lynch SE; Giannobile WV
Tissue Eng; 2006 Jun; 12(6):1441-50. PubMed ID: 16846342
[TBL] [Abstract][Full Text] [Related]
18. Promoting healing with recombinant human platelet-derived growth factor--BB in a previously irradiated problem wound.
Hom DB; Manivel JC
Laryngoscope; 2003 Sep; 113(9):1566-71. PubMed ID: 12972935
[TBL] [Abstract][Full Text] [Related]
19. Preclinical promise of becaplermin (rhPDGF-BB) in wound healing.
LeGrand EK
Am J Surg; 1998 Aug; 176(2A Suppl):48S-54S. PubMed ID: 9777972
[TBL] [Abstract][Full Text] [Related]
20. Effect of rhPDGF-BB on bone turnover during periodontal repair.
Sarment DP; Cooke JW; Miller SE; Jin Q; McGuire MK; Kao RT; McClain PK; McAllister BS; Lynch SE; Giannobile WV
J Clin Periodontol; 2006 Feb; 33(2):135-40. PubMed ID: 16441739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
